| scholarly article | Q13442814 |
| P50 | author | Eng-King Tan | Q67189690 |
| P2093 | author name string | Patrick Ho | |
| Brian W Dymock | |||
| Dario C Angeles | |||
| Kah-Leong Lim | |||
| Zhi-Dong Zhou | |||
| P2860 | cites work | GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1 | Q21144926 |
| LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool | Q24292798 | ||
| MAP1B rescues LRRK2 mutant-mediated cytotoxicity | Q24295033 | ||
| The role of oxidative stress in Parkinson's disease | Q24307946 | ||
| The familial Parkinsonism gene LRRK2 regulates neurite process morphology | Q24317613 | ||
| Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila | Q24322678 | ||
| Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death | Q24323228 | ||
| LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity | Q29615144 | ||
| Parkinson's disease | Q29616302 | ||
| Piceatannol (3,4,3',5'-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor | Q34473126 | ||
| Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models. | Q36015579 | ||
| Pathogenic mutations in Parkinson disease | Q36770206 | ||
| Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts | Q37608238 | ||
| Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria | Q37631959 | ||
| Polyphenols: multipotent therapeutic agents in neurodegenerative diseases | Q38120532 | ||
| Targeting leucine-rich repeat kinase 2 in Parkinson's disease | Q38160939 | ||
| Emerging therapies for Parkinson's disease: from bench to bedside. | Q38214044 | ||
| Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease | Q39237644 | ||
| Thymoquinone protects dopaminergic neurons against MPP+ and rotenone | Q46194199 | ||
| Targeting mitochondria for neuroprotection in Parkinson disease. | Q50675296 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 4 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 288-294 | |
| P577 | publication date | 2016-03-02 | |
| P1433 | published in | Annals of clinical and translational neurology | Q27725312 |
| P1476 | title | Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2 | |
| P478 | volume | 3 |
| Q64070827 | Nutrigenomics as a tool to study the impact of diet on aging and age-related diseases: the approach |
| Q52847929 | Parkinson disease: Insect screens for PD therapies - keep the flies in. |
| Q45814729 | Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity. |
| Q94502456 | Resveratrol Derivatives as Potential Treatments for Alzheimer's and Parkinson's Disease |
| Q39263032 | Targeting LRRK2 in Parkinson's disease: an update on recent developments |
| Q60960522 | The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials |
| Q47126437 | Therapeutic Versatility of Resveratrol Derivatives |
| Q91866682 | Using Drosophila as a platform for drug discovery from natural products in Parkinson's disease |
Search more.